Medicare Enrolled
Dr. Sergey Zhivotenko, MD
Neurology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zhivotenko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zhivotenko?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zhivotenko
Dr. Sergey Zhivotenko is a neurology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zhivotenko performed 3,076 Medicare services across 2,130 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zhivotenko received a total of $18,737 from 63 pharmaceutical and/or device companies across 823 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zhivotenko is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$18,737 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,076
Medicare services
Top 15% in NY for neurology
2,130
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
658 | $81 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
565 | $113 | $152 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
210 | $1 | $10 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
198 | $91 | $117 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
186 | $259 | $334 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
145 | $100 | $136 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
142 | $36 | $79 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
142 | $99 | $167 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
142 | $122 | $188 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
140 | $182 | $243 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
127 | $43 | $76 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
101 | $229 | $292 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
82 | $329 | $421 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $13 | $19 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
64 | $1 | $2 |
| Injection of carpal tunnel | 32 | $81 | $107 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $46 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $155 | $198 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
18 | $425 | $568 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,737
Total received (2018-2024)
Avg $2,677/year across 7 years
Top 18% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
823
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,375 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$361 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,226
2023
$3,324
2022
$3,221
2021
$3,166
2020
$1,903
2019
$1,939
2018
$1,957
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$452
Neurelis, Inc.
$436
MDD US Operations, LLC
$378
ABBVIE INC.
$308
UCB, Inc.
$278
Lilly USA, LLC
$167
Neurocrine Biosciences, Inc.
$157
Axsome Therapeutics, Inc.
$144
SCILEX PHARMACEUTICALS INC.
$141
Azurity Pharmaceuticals, Inc.
$139
Medtronic, Inc.
$132
Amneal Pharmaceuticals LLC
$123
Lundbeck LLC
$122
Kyowa Kirin, Inc.
$81
ACADIA Pharmaceuticals Inc
$75
ARGENX US, INC.
$27
Eisai Inc.
$25
Teva Pharmaceuticals USA, Inc.
$21
Biogen, Inc.
$19
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,386
Neurelis, Inc.
$1,282
UCB, Inc.
$1,004
Eisai Inc.
$894
Lilly USA, LLC
$871
Otsuka America Pharmaceutical, Inc.
$851
Neurocrine Biosciences, Inc.
$785
Avanir Pharmaceuticals, Inc.
$779
SK Life Science, Inc.
$741
Amneal Pharmaceuticals LLC
$665
AbbVie Inc.
$650
ARBOR PHARMACEUTICALS, INC.
$572
ABBVIE INC.
$567
ACADIA Pharmaceuticals Inc
$561
MDD US Operations, LLC
$530
Allergan, Inc.
$505
EISAI INC.
$486
Axsome Therapeutics, Inc.
$435
Avion Pharmaceuticals
$410
Azurity Pharmaceuticals, Inc.
$335
Biogen, Inc.
$302
Teva Pharmaceuticals USA, Inc.
$301
Arbor Pharmaceuticals, Inc.
$269
Biohaven Pharmaceuticals, Inc.
$248
Medtronic, Inc.
$234
Adamas Pharmaceuticals, Inc.
$233
Acorda Therapeutics, Inc
$203
Allergan Inc.
$186
SCILEX PHARMACEUTICALS INC.
$185
GENZYME CORPORATION
$175
Endo Pharmaceuticals Inc.
$151
Assertio Therapeutics, Inc.
$145
Kyowa Kirin, Inc.
$137
Merck Sharp & Dohme Corporation
$129
Novartis Pharmaceuticals Corporation
$126
ASSERTIO THERAPEUTICS, Inc.
$122
Lundbeck LLC
$122
Almatica Pharma LLC
$119
Horizon Therapeutics plc
$109
Impax Laboratories, Inc.
$91
PFIZER INC.
$72
Bausch Health US, LLC
$70
Scilex Pharmaceuticals Inc.
$66
IMPEL PHARMACEUTICALS INC.
$63
Sunovion Pharmaceuticals Inc.
$60
CATALYST PHARMACEUTICALS, INC.
$43
Medtronic USA, Inc.
$43
IDORSIA PHARMACEUTICALS US INC
$42
Vertical Pharmaceuticals, LLC
$42
Merck Sharp & Dohme LLC
$41
GE Healthcare
$39
Horizon Pharma plc
$31
ARGENX US, INC.
$27
GE HEALTHCARE
$26
SI-BONE, Inc.
$26
SI-BONE, INC.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
Abbott Laboratories
$19
Zyla Life Sciences
$18
Alexion Pharmaceuticals, Inc.
$17
Biohaven Pharmaceutical Holding Company Ltd.
$17
GE HealthCare
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 19.6% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Auvelity · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · CREXONT · Cambia · Cenobamate · DIVIGEL · DUEXIS · Dhivy · EDARBI · EMGALITY · Edarbi · Eprontia · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gocovri · Gralise · HORIZANT · Horizant · IFUSE IMPLANT · INBRIJA · INFINITY · INGREZZA · JANUVIA · KISUNLA · KYNMOBI · LEQEMBI · LYRICA · Leqembi · MAYZENT · MIGRANAL · NAMZARIC · NAPRELAN · NASCOBAL · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ongentys · PENNSAID · PERCEPT PC BRAINSENSE · Percept · QULIPTA · QUVIVIQ · RADICAVA · RELISTOR · REXULTI · RYTARY · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIMOVO · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · XADAGO · XCOPRI · ZORVOLEX · ZTLido · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,171
Per 100K population
44.3
County median income
$78,548
Nearest hospital
SOUTH BROOKLYN HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zhivotenko is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with low-engagement industry engagement in the top 18% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zhivotenko experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zhivotenko performed 658 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zhivotenko receive payments from pharmaceutical companies?
Yes. Dr. Zhivotenko received a total of $18,737 from 63 companies across 823 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zhivotenko's costs compare to other neurologists in Brooklyn?
Dr. Zhivotenko's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zhivotenko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Brooklyn
Browse neurologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Neurelis, Inc. Payments to Doctors
See all physicians who received payments from Neurelis, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology